Medtronic Stock Is Still A Great “Buy”
Summary: Medtronic remains a "Buy" due to its undervalued stock, recent product launches, and resolved supply chain issues,...
Tag: MDT
Medtronic: Guidance Raised, Solid Dividend, Shares Still A Bargain
Summary: Medtronic remains a buy due to its attractive valuation and steady EPS growth, despite recent sector-wide selling...
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Summary: Medtronic plc reported Q2 earnings today, with revenues of $8.4bn, up 5% year-on-year, adjusted EPS of $1.26,...
Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Summary: Medtronic is modestly undervalued based on DCF analysis, but slow revenue growth limits upside potential.The...
Medtronic: Undervalued Dividend Aristocrat With High Margins
Summary: Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and...
Medtronic: This Dividend Aristocrat Is Still A Buy Now
Summary: Medtronic is a Dividend Aristocrat with 47 consecutive years of payout growth.The MedTech company exceeded the...
Medtronic: An Undervalued Stock With Durable Competitive Advantages
Summary: Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by...
Medtronic: Is The Company Back?
Summary: Medtronic faced challenges, including poor focus, lack of innovation, and COVID-19 impact, leading to share price...
Medtronic: Healthy Vital Signs Heading Into Earnings
Summary: Medtronic stock underperformed the market, up only 4% in the past year.The options market predicts a 3.3% stock...
Medtronic: Still A Buy Before Earnings
Summary: Medtronic is a strong option for investors seeking both low volatility and consistent dividend growth.I am quite...